Filtering Libraries for Virtual Screening
Virtual screening is a key step in computational drug discovery, allowing you to rapidly evaluate large libraries of compounds to identify promising candidates for further study. Before you begin virtual screening, it is essential to filter your compound library to focus on molecules with properties consistent with successful drugs. This filtering process increases the efficiency of screening and reduces the likelihood of pursuing compounds that are unlikely to succeed due to poor drug-likeness.
Lipinski's Rule of Five is a set of criteria used to evaluate whether a compound is likely to be an orally active drug in humans. The rule states that, in general, an orally active drug has no more than one violation of the following: not more than 5 hydrogen bond donors, not more than 10 hydrogen bond acceptors, a molecular weight under 500 daltons, and a logP value under 5.
12345678910111213141516171819202122232425262728293031323334import pandas as pd from rdkit import Chem from rdkit.Chem import Descriptors def passes_lipinski(mol): mw = Descriptors.MolWt(mol) logp = Descriptors.MolLogP(mol) h_donors = Descriptors.NumHDonors(mol) h_acceptors = Descriptors.NumHAcceptors(mol) return ( mw <= 500 and logp <= 5 and h_donors <= 5 and h_acceptors <= 10 ) # Example SMILES smiles_list = [ "CC(=O)OC1=CC=CC=C1C(=O)O", # Aspirin "CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl", # Chlorpromazine "C1=CC=CC=C1", # Benzene (not drug-like) ] results = [] for smi in smiles_list: mol = Chem.MolFromSmiles(smi) if mol: results.append({ "smiles": smi, "passes_lipinski": passes_lipinski(mol) }) df = pd.DataFrame(results) print(df)
Lipinski's Rule of Five is a widely used guideline to assess the drug-likeness of small molecules. According to this rule, a compound is more likely to be orally active if it meets the following criteria:
- Molecular weight is less than or equal to 500 daltons;
- LogP (octanol-water partition coefficient) is less than or equal to 5;
- No more than 5 hydrogen bond donors (sum of OH and NH groups);
- No more than 10 hydrogen bond acceptors (sum of N and O atoms).
Each of these rules is designed to ensure that a molecule has the right balance of size, solubility, and permeability, which are critical for oral bioavailability. Violating more than one of these rules suggests a compound may have poor absorption or permeation properties.
123456789101112131415161718192021222324252627282930313233from rdkit import RDLogger RDLogger.DisableLog('rdApp.*') # Suppress RDKit warnings compound_data = [ {"name": "Aspirin", "smiles": "CC(=O)OC1=CC=CC=C1C(=O)O"}, {"name": "Chlorpromazine", "smiles": "CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl"}, {"name": "Benzene", "smiles": "C1=CC=CC=C1"}, {"name": "Amoxicillin", "smiles": "CC1(C)SCC(N1C(=O)NC2=CC=CC=C2)C(=O)O"}, ] def passes_lipinski(mol): from rdkit.Chem import Descriptors mw = Descriptors.MolWt(mol) logp = Descriptors.MolLogP(mol) h_donors = Descriptors.NumHDonors(mol) h_acceptors = Descriptors.NumHAcceptors(mol) return ( mw <= 500 and logp <= 5 and h_donors <= 5 and h_acceptors <= 10 ) from rdkit import Chem filtered = [] for compound in compound_data: mol = Chem.MolFromSmiles(compound["smiles"]) if mol and passes_lipinski(mol): filtered.append(compound["name"]) print("Drug-like compounds passing Lipinski's Rule of Five:") for name in filtered: print(name)
Filtering compound libraries using drug-likeness rules such as Lipinski's Rule of Five has a significant impact on the outcomes of virtual screening. By removing compounds that are unlikely to be orally bioavailable, you reduce the number of false positives and focus your computational and experimental resources on candidates with a higher chance of success. However, over-filtering may exclude novel or unconventional drug candidates, so it is important to balance strictness with the goals of your screening project.
To learn more and get more hands-on practice with the Pandas library, we recommend taking the Introduction to Pandas course.
1. What is the purpose of Lipinski's Rule of Five?
2. Which property is NOT part of Lipinski's Rule of Five?
3. Why is filtering important before virtual screening?
Tack för dina kommentarer!
Fråga AI
Fråga AI
Fråga vad du vill eller prova någon av de föreslagna frågorna för att starta vårt samtal
Can you explain what virtual screening is used for in drug discovery?
What are some other drug-likeness rules besides Lipinski's Rule of Five?
How strict should I be when filtering compounds for virtual screening?
Fantastiskt!
Completion betyg förbättrat till 6.25
Filtering Libraries for Virtual Screening
Svep för att visa menyn
Virtual screening is a key step in computational drug discovery, allowing you to rapidly evaluate large libraries of compounds to identify promising candidates for further study. Before you begin virtual screening, it is essential to filter your compound library to focus on molecules with properties consistent with successful drugs. This filtering process increases the efficiency of screening and reduces the likelihood of pursuing compounds that are unlikely to succeed due to poor drug-likeness.
Lipinski's Rule of Five is a set of criteria used to evaluate whether a compound is likely to be an orally active drug in humans. The rule states that, in general, an orally active drug has no more than one violation of the following: not more than 5 hydrogen bond donors, not more than 10 hydrogen bond acceptors, a molecular weight under 500 daltons, and a logP value under 5.
12345678910111213141516171819202122232425262728293031323334import pandas as pd from rdkit import Chem from rdkit.Chem import Descriptors def passes_lipinski(mol): mw = Descriptors.MolWt(mol) logp = Descriptors.MolLogP(mol) h_donors = Descriptors.NumHDonors(mol) h_acceptors = Descriptors.NumHAcceptors(mol) return ( mw <= 500 and logp <= 5 and h_donors <= 5 and h_acceptors <= 10 ) # Example SMILES smiles_list = [ "CC(=O)OC1=CC=CC=C1C(=O)O", # Aspirin "CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl", # Chlorpromazine "C1=CC=CC=C1", # Benzene (not drug-like) ] results = [] for smi in smiles_list: mol = Chem.MolFromSmiles(smi) if mol: results.append({ "smiles": smi, "passes_lipinski": passes_lipinski(mol) }) df = pd.DataFrame(results) print(df)
Lipinski's Rule of Five is a widely used guideline to assess the drug-likeness of small molecules. According to this rule, a compound is more likely to be orally active if it meets the following criteria:
- Molecular weight is less than or equal to 500 daltons;
- LogP (octanol-water partition coefficient) is less than or equal to 5;
- No more than 5 hydrogen bond donors (sum of OH and NH groups);
- No more than 10 hydrogen bond acceptors (sum of N and O atoms).
Each of these rules is designed to ensure that a molecule has the right balance of size, solubility, and permeability, which are critical for oral bioavailability. Violating more than one of these rules suggests a compound may have poor absorption or permeation properties.
123456789101112131415161718192021222324252627282930313233from rdkit import RDLogger RDLogger.DisableLog('rdApp.*') # Suppress RDKit warnings compound_data = [ {"name": "Aspirin", "smiles": "CC(=O)OC1=CC=CC=C1C(=O)O"}, {"name": "Chlorpromazine", "smiles": "CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl"}, {"name": "Benzene", "smiles": "C1=CC=CC=C1"}, {"name": "Amoxicillin", "smiles": "CC1(C)SCC(N1C(=O)NC2=CC=CC=C2)C(=O)O"}, ] def passes_lipinski(mol): from rdkit.Chem import Descriptors mw = Descriptors.MolWt(mol) logp = Descriptors.MolLogP(mol) h_donors = Descriptors.NumHDonors(mol) h_acceptors = Descriptors.NumHAcceptors(mol) return ( mw <= 500 and logp <= 5 and h_donors <= 5 and h_acceptors <= 10 ) from rdkit import Chem filtered = [] for compound in compound_data: mol = Chem.MolFromSmiles(compound["smiles"]) if mol and passes_lipinski(mol): filtered.append(compound["name"]) print("Drug-like compounds passing Lipinski's Rule of Five:") for name in filtered: print(name)
Filtering compound libraries using drug-likeness rules such as Lipinski's Rule of Five has a significant impact on the outcomes of virtual screening. By removing compounds that are unlikely to be orally bioavailable, you reduce the number of false positives and focus your computational and experimental resources on candidates with a higher chance of success. However, over-filtering may exclude novel or unconventional drug candidates, so it is important to balance strictness with the goals of your screening project.
To learn more and get more hands-on practice with the Pandas library, we recommend taking the Introduction to Pandas course.
1. What is the purpose of Lipinski's Rule of Five?
2. Which property is NOT part of Lipinski's Rule of Five?
3. Why is filtering important before virtual screening?
Tack för dina kommentarer!